HA
MRNA icon

H2O AM’s Moderna MRNA Stock Holding History

H2O AM’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,000
Closed -$963K – 110
2020
Q2 		$963K Buy
+15,000
New +$821K 1.02% 29

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

H2O AM's MRNA Position: Q3 2020 in Review

H2O AM sold out of Moderna (MRNA) in Q3 2020, closing a stake of 15,000 shares — an estimated $963K sold.

H2O AM first reported a position in MRNA in Q2 2020 and held it in 1 quarter. The position peaked at $963K in Q2 2020. 548 funds tracked by Wall St. Rank hold MRNA as of Q3 2020.

  • H2O AM reported no remaining Moderna position as of Q3 2020 after selling out during the quarter.
  • H2O AM sold 15,000 Moderna shares in Q3 2020, an estimated $963K.
  • H2O AM first reported a position in Moderna in Q2 2020 and held it in 1 quarter.
  • H2O AM's Moderna position peaked at $963K in Q2 2020.
  • 548 funds tracked by Wall St. Rank held Moderna as of Q3 2020.

Based on H2O AM's 13F filing for Q3 2020, filed 12 Nov 2020.